Streetbeat News

Revenues

VVX

V2X has raised its FY24 revenue guidance from a range of $4.10 billion - $4.20 billion to $4.175 billion - $4.275 billion, surpassing the estimated $4.176 billion.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:28 am

VVX

V2X (NYSE:VVX) reported Q2 2024 earnings of $0.83 per share, significantly beating the analyst estimate of $0.19. Sales also surpassed expectations, reaching $1.072 billion. Despite the earnings beat, EPS decreased by 24.55% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:26 am

BAX

Baxter International Inc. (BAX) expects Q3 sales growth of 3%-4% on a reported basis and 4%-5% on a constant currency basis. The company also projects adjusted EPS of $0.77-$0.79, surpassing the consensus estimate of $0.66.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:22 am

BAX

Baxter International Inc. has updated its 2024 sales growth expectations to approximately 3% on both a reported and constant currency basis, compared to its prior guidance of 2% and 2%-3%, respectively.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:20 am

STVN

Stevanato Group has provided its financial guidance for FY24, expecting adjusted EPS to be between €0.48 and €0.50, and revenue to range from €1.090 billion to €1.110 billion.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:20 am

RYTM

Rhythm Pharmaceuticals announced that its cash on-hand is expected to support planned operations into 2026. The company anticipates approximately $250 million to $270 million in Non-GAAP Operating Expenses for the year ending December 31, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:20 am

BLMN

Bloomin' Brands has projected its Q3 adjusted EPS to be between $0.17 and $0.25, which is below the estimated $0.39. The company also expects U.S. comparable restaurant sales to be down 2% to flat.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:19 am

HGTY

Hagerty has raised its FY24 revenue guidance from $1.150B-$1.170B to $1.160B-$1.180B, which is still below the $1.69B estimate.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:18 am

TDG

TransDigm Group (NYSE:TDG) reported Q3 2024 adjusted EPS of $9.00, beating the $8.56 estimate. Sales were $2.046 billion, surpassing the $2.005 billion estimate and marking a 17.32% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:17 am

SOPH

SOPHiA GENETICS has revised its FY24 revenue guidance to $65M-$67M, which is below the previous estimate of $76.631M.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:16 am